These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 27357347)

  • 1. 18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers.
    Smith R; Puschmann A; Schöll M; Ohlsson T; van Swieten J; Honer M; Englund E; Hansson O
    Brain; 2016 Sep; 139(Pt 9):2372-9. PubMed ID: 27357347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 18F-AV-1451 positron emission tomography in Alzheimer's disease and progressive supranuclear palsy.
    Passamonti L; Vázquez Rodríguez P; Hong YT; Allinson KS; Williamson D; Borchert RJ; Sami S; Cope TE; Bevan-Jones WR; Jones PS; Arnold R; Surendranathan A; Mak E; Su L; Fryer TD; Aigbirhio FI; O'Brien JT; Rowe JB
    Brain; 2017 Mar; 140(3):781-791. PubMed ID: 28122879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages.
    Schwarz AJ; Yu P; Miller BB; Shcherbinin S; Dickson J; Navitsky M; Joshi AD; Devous MD; Mintun MS
    Brain; 2016 May; 139(Pt 5):1539-50. PubMed ID: 26936940
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Tsai RM; Bejanin A; Lesman-Segev O; LaJoie R; Visani A; Bourakova V; O'Neil JP; Janabi M; Baker S; Lee SE; Perry DC; Bajorek L; Karydas A; Spina S; Grinberg LT; Seeley WW; Ramos EM; Coppola G; Gorno-Tempini ML; Miller BL; Rosen HJ; Jagust W; Boxer AL; Rabinovici GD
    Alzheimers Res Ther; 2019 Jan; 11(1):13. PubMed ID: 30704514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tau PET Imaging with [18F]PM-PBB3 in Frontotemporal Dementia with MAPT Mutation.
    Su Y; Fu J; Yu J; Zhao Q; Guan Y; Zuo C; Li M; Tan H; Cheng X
    J Alzheimers Dis; 2020; 76(1):149-157. PubMed ID: 32444551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Head to head comparison of [
    Jang YK; Lyoo CH; Park S; Oh SJ; Cho H; Oh M; Ryu YH; Choi JY; Rabinovici GD; Kim HJ; Moon SH; Jang H; Lee JS; Jagust WJ; Na DL; Kim JS; Seo SW
    Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):432-442. PubMed ID: 29143870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo
    Jones DT; Knopman DS; Graff-Radford J; Syrjanen JA; Senjem ML; Schwarz CG; Dheel C; Wszolek Z; Rademakers R; Kantarci K; Petersen RC; Jack CR; Lowe VJ; Boeve BF
    Neurology; 2018 Mar; 90(11):e947-e954. PubMed ID: 29440563
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Shen XN; Miao D; Li JQ; Tan CC; Cao XP; Tan L; Yu JT
    Aging (Albany NY); 2019 Jan; 11(3):874-884. PubMed ID: 30708351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [
    Wolters EE; Papma JM; Verfaillie SCJ; Visser D; Weltings E; Groot C; van der Ende EL; Giannini LAA; Tuncel H; Timmers T; Boellaard R; Yaqub M; van Assema DME; Kuijper DA; Segbers M; Rozemuller AJM; Barkhof F; Windhorst AD; van der Flier WM; Pijnenburg YAL; Scheltens P; van Berckel BNM; van Swieten JC; Ossenkoppele R; Seelaar H
    Neurology; 2021 Sep; 97(10):e1017-e1030. PubMed ID: 34210823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional Distribution, Asymmetry, and Clinical Correlates of Tau Uptake on [18F]AV-1451 PET in Atypical Alzheimer's Disease.
    Tetzloff KA; Graff-Radford J; Martin PR; Tosakulwong N; Machulda MM; Duffy JR; Clark HM; Senjem ML; Schwarz CG; Spychalla AJ; Drubach DA; Jack CR; Lowe VJ; Josephs KA; Whitwell JL
    J Alzheimers Dis; 2018; 62(4):1713-1724. PubMed ID: 29614676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [
    Whitwell JL; Lowe VJ; Tosakulwong N; Weigand SD; Senjem ML; Schwarz CG; Spychalla AJ; Petersen RC; Jack CR; Josephs KA
    Mov Disord; 2017 Jan; 32(1):124-133. PubMed ID: 27787958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frontotemporal dementia with the V337M
    Spina S; Schonhaut DR; Boeve BF; Seeley WW; Ossenkoppele R; O'Neil JP; Lazaris A; Rosen HJ; Boxer AL; Perry DC; Miller BL; Dickson DW; Parisi JE; Jagust WJ; Murray ME; Rabinovici GD
    Neurology; 2017 Feb; 88(8):758-766. PubMed ID: 28130473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer's disease.
    Schöll M; Ossenkoppele R; Strandberg O; Palmqvist S; ; Jögi J; Ohlsson T; Smith R; Hansson O
    Brain; 2017 Sep; 140(9):2286-2294. PubMed ID: 29050382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early stages of tau pathology and its associations with functional connectivity, atrophy and memory.
    Berron D; Vogel JW; Insel PS; Pereira JB; Xie L; Wisse LEM; Yushkevich PA; Palmqvist S; Mattsson-Carlgren N; Stomrud E; Smith R; Strandberg O; Hansson O
    Brain; 2021 Oct; 144(9):2771-2783. PubMed ID: 33725124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
    Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-MK-6240 tau-PET in genetic frontotemporal dementia.
    Levy JP; Bezgin G; Savard M; Pascoal TA; Finger E; Laforce R; Sonnen JA; Soucy JP; Gauthier S; Rosa-Neto P; Ducharme S
    Brain; 2022 Jun; 145(5):1763-1772. PubMed ID: 34664612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid and tau PET demonstrate region-specific associations in normal older people.
    Lockhart SN; Schöll M; Baker SL; Ayakta N; Swinnerton KN; Bell RK; Mellinger TJ; Shah VD; O'Neil JP; Janabi M; Jagust WJ
    Neuroimage; 2017 Apr; 150():191-199. PubMed ID: 28232190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct patterns of amyloid-dependent tau accumulation in Lewy body diseases.
    Lee SH; Cho H; Choi JY; Lee JH; Ryu YH; Lee MS; Lyoo CH
    Mov Disord; 2018 Feb; 33(2):262-272. PubMed ID: 29168583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo tau PET imaging in dementia: Pathophysiology, radiotracer quantification, and a systematic review of clinical findings.
    Hall B; Mak E; Cervenka S; Aigbirhio FI; Rowe JB; O'Brien JT
    Ageing Res Rev; 2017 Jul; 36():50-63. PubMed ID: 28315409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Entorhinal Tau Predicts Hippocampal Activation and Memory Deficits in Alzheimer's Disease.
    Richter N; Bischof GN; Dronse J; Nellessen N; Neumaier B; Langen KJ; Drzezga A; Fink GR; van Eimeren T; Kukolja J; Onur OA
    J Alzheimers Dis; 2020; 78(4):1601-1614. PubMed ID: 33164934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.